Factors identified for increased post-surgery weight gain among breast cancer survivors
the ONA take:
According to a new study published in the journal BMC Cancer, researchers have found that average long-term weight gain among breast cancer survivors is small, but certain subgroups of women experience greater weight gain associated with adverse health.
For the study, researchers sought to investigate body weight changes following breast cancer over 6 years and whether weight changes are linked with behavioral, diagnostic, personal, or treatment characteristics. Researchers identified 287 Australian women diagnosed with early-stage invasive breast cancer.
Results showed that 57% of women were overweight or obese at 6 months post-surgery, which increased to 68% at 72 months post-surgery. Researchers found that 24% of participants experienced clinically significant weight gain between 6 and 18 months and 39% experienced clinically significant weight gain between 6 and 72 months post-surgery.
In addition, researchers found that more extensive lymph node removal, receiving radiation therapy, being treated on the non-dominant side, and decreased physical activity levels at 6 months post-surgery were associated with higher body weights after breast cancer.
The findings suggest that healthy weight education should be integrated into breast cancer care to improve the quality of cancer survivorship.
Average long-term weight gain among breast cancer survivors is small, but certain subgroups experience greater gain associated with adverse health.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|